Pliaglis Cream
Product Images NDC 71085-100

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Pliaglis (NDC 71085-100). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ipg Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Description (Label1)

Dosage: Apply to affected area. See package for additional information. (Lidocaine and Tetracaine Cream 7%/7%) This cream is for topical use only and is a combination of Lidocaine and Tetracaine.Ensure to read the package for specific instructions. Note: Avoid exposing the product to varnish, copy, or color. This flap is for lot number and expiration date printing.*

FDA Label Image

Image Description (Image 100 1)

FDA Label Image

Image Description (Image 100 2)

FDA Label Image

Image Description (Image 100 3)

FDA Label Image

Image Description (Label2)

This description provides information on the use and warnings for Pliaglis, a cream containing Lidocaine and Tetracaine for topical use. It includes details on dosage, how to apply, and storage instructions. The cream is manufactured in Canada for IPG Pharmaceuticals, Inc. and should be discarded after storing at room temperature for 3 months. Remember to keep the product away from children, wash hands after use, and avoid contact with eyes.*

FDA Label Image

Image Description (Structure 1)

FDA Label Image

Image Description (Structure 2)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.